Picture of Anebulo Pharmaceuticals logo

ANEB — Anebulo Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Anebulo Pharmaceuticals reports Q4 results

Sept 9 (Reuters) - Anebulo Pharmaceuticals Inc  ANEB.O :
    * ANEBULO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FISCAL
YEAR
2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS PROGRESS
    * ANEBULO PHARMACEUTICALS INC - CASH BALANCE WAS $14.5
MILLION AS
OF JUNE 30, 2022
    * ANEBULO PHARMACEUTICALS INC - NET LOSS IN Q4 OF FISCAL
2022 WAS
$2.3 MILLION, OR $0.10 PER SHARE

Source text for Eikon:  ID:nBw3MqwDda 
Further company coverage:  ANEB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Anebulo Pharmaceuticals

See all news